Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
39.98
-2.74 (-6.41%)
Mar 31, 2025, 10:53 AM EDT - Market open

Akero Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Akero Therapeutics stock have an average target of 76.29, with a low estimate of 38 and a high estimate of 109. The average target predicts an increase of 90.82% from the current stock price of 39.98.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $38 $76.29 $75 $109
Change -4.95% +90.82% +87.59% +172.64%

Analyst Ratings

The average analyst rating for Akero Therapeutics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 344555
Buy 533444
Hold 111000
Sell 000000
Strong Sell 000000
Total 988999

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$72$75
Strong Buy Maintains $72$75 +87.59% Mar 3, 2025
UBS
UBS
Strong Buy
Maintains
$42$109
Strong Buy Maintains $42$109 +172.64% Jan 31, 2025
B of A Securities
B of A Securities
Strong Buy
Upgrades
$35$63
Strong Buy Upgrades $35$63 +57.58% Jan 30, 2025
Morgan Stanley
Morgan Stanley
Buy
Maintains
$46$96
Buy Maintains $46$96 +140.12% Jan 28, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$65$80
Strong Buy Maintains $65$80 +100.10% Jan 28, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 345.98M
Revenue Next Year
n/a
EPS This Year
-4.77
from -3.75
EPS Next Year
-4.98
from -4.77
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
-4.23M29.59M67.02M345.98M
Revenue Growth
--600.26%126.49%416.20%---
EPS
-2.52-2.89-2.87-2.89-3.75-4.77-4.98-1.19
EPS Growth
--------
Forward PE
--------
No. Analysts -----12103
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a 30.5M 121.9M
Avg n/a 4.2M 29.6M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High - -
2,783.3%
Avg - -
600.3%
Low - - -

EPS Forecast

EPS 20252026202720282029
High -4.06 -4.11 -1.23
Avg -4.77 -4.98 -1.19
Low -6.12 -6.44 -1.15

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.